Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 210278
Company: GLENMARK PHARMS LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
TOPIRAMATE TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE;ORAL Prescription AB2 No No
TOPIRAMATE TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE;ORAL Prescription AB2 No No
TOPIRAMATE TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription AB2 No No
TOPIRAMATE TOPIRAMATE 150MG CAPSULE, EXTENDED RELEASE;ORAL Prescription AB2 No No
TOPIRAMATE TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription AB2 No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/01/2021 ORIG-1 Approval STANDARD Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/210278Orig1s000ltr.pdf

TOPIRAMATE

CAPSULE, EXTENDED RELEASE;ORAL; 25MG
TE Code = AB2

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
QUDEXY XR TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB2 205122 UPSHER SMITH LABS
TOPIRAMATE TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB2 210278 GLENMARK PHARMS LTD

CAPSULE, EXTENDED RELEASE;ORAL; 50MG
TE Code = AB2

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
QUDEXY XR TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB2 205122 UPSHER SMITH LABS
TOPIRAMATE TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB2 210278 GLENMARK PHARMS LTD

CAPSULE, EXTENDED RELEASE;ORAL; 100MG
TE Code = AB2

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
QUDEXY XR TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB2 205122 UPSHER SMITH LABS
TOPIRAMATE TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB2 210278 GLENMARK PHARMS LTD

CAPSULE, EXTENDED RELEASE;ORAL; 150MG
TE Code = AB2

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
QUDEXY XR TOPIRAMATE 150MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB2 205122 UPSHER SMITH LABS
TOPIRAMATE TOPIRAMATE 150MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB2 210278 GLENMARK PHARMS LTD

CAPSULE, EXTENDED RELEASE;ORAL; 200MG
TE Code = AB2

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
QUDEXY XR TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB2 205122 UPSHER SMITH LABS
TOPIRAMATE TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB2 210278 GLENMARK PHARMS LTD

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English